The World Market for Unmixed Vitamin E and Derivatives: A 2024 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for unmixed vitamin E and derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for unmixed vitamin E and derivatives for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.
"Unmixed vitamin E and derivatives" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "unmixed vitamin E and derivatives" is 54115.
- 1 METHODOLOGY
- 1.1 OUR APPROACH
- 2 THE WORLD MARKET
- 2.1 EXPORTS
- 2.1.1 THE WORLD MARKET: UNMIXED VITAMIN E AND DERIVATIVES EXPORT SUPPLIES IN 2024
- 2.2 IMPORTS
- 2.2.1 THE WORLD MARKET: IMPORTED UNMIXED VITAMIN E AND DERIVATIVES IN 2024
- 3 EXPORTS
- 3.1 AFRICA: EXPORT SUPPLIES OF UNMIXED VITAMIN E AND DERIVATIVES IN 2024
- 3.1.1 EXECUTIVE SUMMARY
- 3.1.2 ESWATINI
- 3.1.3 KENYA
- 3.1.4 SOUTH AFRICA
- 3.2 ASIA: EXPORT SUPPLIES OF UNMIXED VITAMIN E AND DERIVATIVES IN 2024
- 3.2.1 EXECUTIVE SUMMARY
- 3.2.2 CHINA
- 3.2.3 HONG KONG
- 3.2.4 INDIA
- 3.2.5 INDONESIA
- 3.2.6 JAPAN
- 3.2.7 MALAYSIA
- 3.2.8 SINGAPORE
- 3.2.9 SOUTH KOREA
- 3.2.10 TAIWAN
- 3.3 EUROPE: EXPORT SUPPLIES OF UNMIXED VITAMIN E AND DERIVATIVES IN 2024
- 3.3.1 EXECUTIVE SUMMARY
- 3.3.2 AUSTRIA
- 3.3.3 BELARUS
- 3.3.4 BELGIUM
- 3.3.5 CYPRUS
- 3.3.6 DENMARK
- 3.3.7 ESTONIA
- 3.3.8 FINLAND
- 3.3.9 FRANCE
- 3.3.10 GERMANY
- 3.3.11 HUNGARY
- 3.3.12 ICELAND
- 3.3.13 ITALY
- 3.3.14 LATVIA
- 3.3.15 LITHUANIA
- 3.3.16 POLAND
- 3.3.17 PORTUGAL
- 3.3.18 RUSSIA
- 3.3.19 SLOVAKIA
- 3.3.20 SPAIN
- 3.3.21 SWEDEN
- 3.3.22 SWITZERLAND
- 3.3.23 THE CZECH REPUBLIC
- 3.3.24 THE NETHERLANDS
- 3.3.25 THE UNITED KINGDOM
- 3.4 LATIN AMERICA: EXPORT SUPPLIES OF UNMIXED VITAMIN E AND DERIVATIVES IN 2024
- 3.4.1 EXECUTIVE SUMMARY
- 3.4.2 ARGENTINA
- 3.4.3 BRAZIL
- 3.4.4 COLOMBIA
- 3.4.5 ECUADOR
- 3.4.6 GUATEMALA
- 3.4.7 MEXICO
- 3.4.8 PANAMA
- 3.4.9 URUGUAY
- 3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF UNMIXED VITAMIN E AND DERIVATIVES IN 2024
- 3.5.1 EXECUTIVE SUMMARY
- 3.5.2 CANADA
- 3.5.3 THE UNITED STATES
- 3.6 OCEANIA: EXPORT SUPPLIES OF UNMIXED VITAMIN E AND DERIVATIVES IN 2024
- 3.6.1 EXECUTIVE SUMMARY
- 3.6.2 AUSTRALIA
- 3.6.3 NEW ZEALAND
- 4 IMPORTS
- 4.1 AFRICA: UNMIXED VITAMIN E AND DERIVATIVES IMPORTS IN 2024
- 4.1.1 EXECUTIVE SUMMARY
- 4.1.2 ALGERIA
- 4.1.3 CAMEROON
- 4.1.4 COTE D'IVOIRE
- 4.1.5 EGYPT
- 4.1.6 MOROCCO
- 4.1.7 NIGERIA
- 4.1.8 SENEGAL
- 4.1.9 SOUTH AFRICA
- 4.1.10 ZIMBABWE
- 4.2 ASIA: UNMIXED VITAMIN E AND DERIVATIVES IMPORTS IN 2024
- 4.2.1 EXECUTIVE SUMMARY
- 4.2.2 CHINA
- 4.2.3 HONG KONG
- 4.2.4 INDIA
- 4.2.5 INDONESIA
- 4.2.6 JAPAN
- 4.2.7 MALAYSIA
- 4.2.8 NEPAL
- 4.2.9 SINGAPORE
- 4.2.10 SOUTH KOREA
- 4.2.11 SRI LANKA
- 4.2.12 TAIWAN
- 4.2.13 THAILAND
- 4.2.14 THE PHILIPPINES
- 4.2.15 VIETNAM
- 4.3 EUROPE: UNMIXED VITAMIN E AND DERIVATIVES IMPORTS IN 2024
- 4.3.1 EXECUTIVE SUMMARY
- 4.3.2 AUSTRIA
- 4.3.3 BELARUS
- 4.3.4 BELGIUM
- 4.3.5 BOSNIA AND HERZEGOVINA
- 4.3.6 BULGARIA
- 4.3.7 CROATIA
- 4.3.8 CYPRUS
- 4.3.9 DENMARK
- 4.3.10 ESTONIA
- 4.3.11 FINLAND
- 4.3.12 FRANCE
- 4.3.13 GERMANY
- 4.3.14 GREECE
- 4.3.15 HUNGARY
- 4.3.16 ICELAND
- 4.3.17 IRELAND
- 4.3.18 ITALY
- 4.3.19 KAZAKHSTAN
- 4.3.20 LATVIA
- 4.3.21 LITHUANIA
- 4.3.22 LUXEMBOURG
- 4.3.23 NORWAY
- 4.3.24 POLAND
- 4.3.25 PORTUGAL
- 4.3.26 ROMANIA
- 4.3.27 RUSSIA
- 4.3.28 SLOVAKIA
- 4.3.29 SLOVENIA
- 4.3.30 SPAIN
- 4.3.31 SWEDEN
- 4.3.32 SWITZERLAND
- 4.3.33 THE CZECH REPUBLIC
- 4.3.34 THE NETHERLANDS
- 4.3.35 THE UNITED KINGDOM
- 4.3.36 UKRAINE
- 4.4 LATIN AMERICA: UNMIXED VITAMIN E AND DERIVATIVES IMPORTS IN 2024
- 4.4.1 EXECUTIVE SUMMARY
- 4.4.2 ARGENTINA
- 4.4.3 BOLIVIA
- 4.4.4 BRAZIL
- 4.4.5 CHILE
- 4.4.6 COLOMBIA
- 4.4.7 ECUADOR
- 4.4.8 EL SALVADOR
- 4.4.9 GUATEMALA
- 4.4.10 HONDURAS
- 4.4.11 MEXICO
- 4.4.12 PANAMA
- 4.4.13 PERU
- 4.4.14 URUGUAY
- 4.5 NORTH AMERICA & THE CARIBBEAN: UNMIXED VITAMIN E AND DERIVATIVES IMPORTS IN 2024
- 4.5.1 EXECUTIVE SUMMARY
- 4.5.2 CANADA
- 4.5.3 JAMAICA
- 4.5.4 THE DOMINICAN REPUBLIC
- 4.5.5 THE UNITED STATES
- 4.6 OCEANIA: UNMIXED VITAMIN E AND DERIVATIVES IMPORTS IN 2024
- 4.6.1 EXECUTIVE SUMMARY
- 4.6.2 AUSTRALIA
- 4.6.3 NEW ZEALAND
- 4.7 THE MIDDLE EAST: UNMIXED VITAMIN E AND DERIVATIVES IMPORTS IN 2024
- 4.7.1 EXECUTIVE SUMMARY
- 4.7.2 ARMENIA
- 4.7.3 ISRAEL
- 4.7.4 JORDAN
- 4.7.5 KUWAIT
- 4.7.6 LEBANON
- 4.7.7 OMAN
- 4.7.8 PAKISTAN
- 4.7.9 TURKEY
- 5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
- 5.1 DISCLAIMERS & SAFE HARBOR
- 5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook